Lingxiao Xing

2.2k citations
43 papers · 1.6k indexed · h-index 20
Topics
Cancer-related molecular mechanisms research (11 papers)RNA modifications and cancer (10 papers)MicroRNA in disease regulation (9 papers)
Partner nations
ChinaUnited States

In The Last Decade

Lingxiao Xing

40 papers receiving 1.6k citations

Peers

Lingxiao Xing
Comparison fields: 5 of 95
  • Molecular Biology 1.2k
  • Cancer Research 1.0k
  • Plant Science 194
  • Pulmonary and Respiratory Medicine 183
  • Oncology 161
Replace Juan Wu with:
Juan Wu China
Xuemei Li China
Meiying Luo China
Gabrielle S. Le Provost United States
Minghui He China
Xiaojun Zha China
Yi Zhu China
Xiaofeng Jin China
Easwari Kumaraswamy United States
Yao Kong China
Lingxiao Xing relative to Juan Wu China Juan Wu's profile →
Citations per field
00.5×3.0×
Juan Wu · 1×
Citations per year

Countries citing papers authored by Lingxiao Xing

Since Specialization
Citations

This map shows the geographic impact of Lingxiao Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiao Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiao Xing more than expected).

Fields of papers citing papers by Lingxiao Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxiao Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiao Xing. The network helps show where Lingxiao Xing may publish in the future.

Co-authorship network of co-authors of Lingxiao Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxiao Xing. A scholar is included among the top collaborators of Lingxiao Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxiao Xing. Lingxiao Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 7
3 18
4 11
5 11
6 72
7 12
8 72
9 8
10 19
11 30
12 204
13 19
14 2
15 37
16 204
17
Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines.
8
18 1
19 1
20 4

About Lingxiao Xing

Lingxiao Xing is a scholar working on Cancer Research, Biophysics and Applied Microbiology and Biotechnology, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.2k citations) and Oncology (161 citations). Lingxiao Xing has collaborated with scholars based in China and United States. Frequent co-authors include Feng Jiang, Hong‐Bin Fang, Nevins W. Todd, Lei Yu, Haitao Shen, Xianghong Zhang, Howard Zhang, Sanford A. Stass, Ying Xie and Ruth L. Katz. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026